BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deo KM, Pages BJ, Ang DL, Gordon CP, Aldrich-Wright JR. Transition Metal Intercalators as Anticancer Agents-Recent Advances. Int J Mol Sci 2016;17:E1818. [PMID: 27809241 DOI: 10.3390/ijms17111818] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Shahabadi N, Hadidi S. Cu(I)-Phospine complex exhibits temperature-dependent DNA intercalative binding: Insights from spectroscopic and molecular modeling studies. Inorganica Chimica Acta 2022. [DOI: 10.1016/j.ica.2022.121192] [Reference Citation Analysis]
2 Swaminathan S, Haribabu J, Balakrishnan N, Vasanthakumar P, Karvembu R. Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade. Coordination Chemistry Reviews 2022;459:214403. [DOI: 10.1016/j.ccr.2021.214403] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Zhang C, Liu X, Tan L. Interaction of arene ruthenium(II) complexes [(η6-C6H6)Ru(L)Cl]PF6 (L = o-fpip and p-fpip) with the RNA triplex poly(U)*poly(A)•poly(U). J Inorg Biochem 2022;232:111813. [PMID: 35405487 DOI: 10.1016/j.jinorgbio.2022.111813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tyagi K, Dixit T, Venkatesh V. Recent advances in catalytic anticancer drugs: Mechanistic investigations and future prospects. Inorganica Chimica Acta 2022;533:120754. [DOI: 10.1016/j.ica.2021.120754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Irving KL, King JJ, Waller ZAE, Evans CW, Smith NM. Stability and context of intercalated motifs (i-motifs) for biological applications. Biochimie 2022:S0300-9084(22)00052-9. [PMID: 35259471 DOI: 10.1016/j.biochi.2022.03.001] [Reference Citation Analysis]
6 Gordon AT, Abosede OO, Ntsimango S, Hosten EC, Myeza N, Eyk AV, Harmse L, Ogunlaja AS. Synthesis and anticancer evaluation of copper(II)- and manganese(II)- theophylline mixed ligand complexes. Polyhedron 2022;214:115649. [DOI: 10.1016/j.poly.2022.115649] [Reference Citation Analysis]
7 Mumblat H, Martinez-Conde A, Braten O, Munster M, Dor-On E, Schneiderman RS, Porat Y, Voloshin T, Davidi S, Blatt R, Shteingauz A, Tempel-Brami C, Zeevi E, Lajterer C, Shmueli Y, Danilov S, Haber A, Giladi M, Weinberg U, Kinzel A, Palti Y. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models. Lung Cancer 2021;160:99-110. [PMID: 34482104 DOI: 10.1016/j.lungcan.2021.08.011] [Reference Citation Analysis]
8 Rocha JS, Pereira GB, Oliveira GP, Lima MA, Araujo-neto JH, Pinto LS, Forim MR, Zanetti RD, Netto AV, Castellano EE, Rocha FV. Synthesis and characterization of silver(I) complexes bearing phenanthroline derivatives as ligands: Cytotoxicity and DNA interaction evaluation. Inorganic Chemistry Communications 2021;131:108757. [DOI: 10.1016/j.inoche.2021.108757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharfalddin AA, Emwas AH, Jaremko M, Hussien MA. Practical and Computational Studies of Bivalence Metal Complexes of Sulfaclozine and Biological Studies. Front Chem 2021;9:644691. [PMID: 34211959 DOI: 10.3389/fchem.2021.644691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Choroba K, Machura B, Szlapa-Kula A, Malecki JG, Raposo L, Roma-Rodrigues C, Cordeiro S, Baptista PV, Fernandes AR. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties. Eur J Med Chem 2021;218:113404. [PMID: 33823390 DOI: 10.1016/j.ejmech.2021.113404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Arlt S, Petković V, Ludwig G, Eichhorn T, Lang H, Rüffer T, Mijatović S, Maksimović-Ivanić D, Kaluđerović GN. Arene Ruthenium(II) Complexes Bearing the κ-P or κ-P,κ-S Ph2P(CH2)3SPh Ligand. Molecules 2021;26:1860. [PMID: 33806101 DOI: 10.3390/molecules26071860] [Reference Citation Analysis]
12 Adams M, Sullivan MP, Tong KKH, Goldstone DC, Hanif M, Jamieson SMF, Hartinger CG. Mustards-Derived Terpyridine-Platinum Complexes as Anticancer Agents: DNA Alkylation vs Coordination. Inorg Chem 2021;60:2414-24. [PMID: 33497565 DOI: 10.1021/acs.inorgchem.0c03317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Al-harbi SA, Al-saidi HM, Debbabi KF, Allehyani ES, Alqorashi AA, Emara AA. Design and anti-tumor evaluation of new platinum(II) and copper(II) complexes of nitrogen compounds containing selenium moieties. Journal of Saudi Chemical Society 2020;24:982-95. [DOI: 10.1016/j.jscs.2020.10.006] [Reference Citation Analysis]
14 Popov A, Klimovich A, Styshova O, Moskovkina T, Shchekotikhin A, Grammatikova N, Dezhenkova L, Kaluzhny D, Deriabin P, Gerasimenko A, Udovenko A, Stonik V. Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative. Int J Mol Med 2020;46:1335-46. [PMID: 32945360 DOI: 10.3892/ijmm.2020.4693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Rukk NS, Kuzmina LG, Davydova GA, Buzanov GA, Belus SK, Kozhukhova EI, Retivov VM, Ivanova TV, Krasnoperova VN, Bolotin BM. Zinc(II) halide and copper(II) bromide complexes with caffeine: structures, physicochemical properties, and biological activity. Russ Chem Bull 2020;69:1394-400. [DOI: 10.1007/s11172-020-2914-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Czarnomysy R, Radomska D, Muszyńska A, Hermanowicz JM, Prokop I, Bielawska A, Bielawski K. Evaluation of the Anticancer Activities of Novel Transition Metal Complexes with Berenil and Nitroimidazole. Molecules 2020;25:E2860. [PMID: 32575817 DOI: 10.3390/molecules25122860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Liu M, Song X, Wu Y, Qian J, Xu J. Cu( ii )-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis. Dalton Trans 2020;49:114-23. [DOI: 10.1039/c9dt03641e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zheng XT, Tan YN. Recent development of nucleic acid nanosensors to detect sequence-specific binding interactions: From metal ions, small molecules to proteins and pathogens. Sens Int 2020;1:100034. [PMID: 34766041 DOI: 10.1016/j.sintl.2020.100034] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Pages BJ, Gurung SP, McQuaid K, Hall JP, Cardin CJ, Brazier JA. Stabilization of Long-Looped i-Motif DNA by Polypyridyl Ruthenium Complexes. Front Chem 2019;7:744. [PMID: 31750292 DOI: 10.3389/fchem.2019.00744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Herry B, Batchelor LK, Roufosse B, Romano D, Baumgartner J, Borzova M, Reifenstahl T, Collins T, Benamrane A, Weggelaar J, Correia MC, Dyson PJ, Blom B. Heterobimetallic Ru(μ-dppm)Fe and homobimetallic Ru(μ-dppm)Ru complexes as potential anti-cancer agents. Journal of Organometallic Chemistry 2019;901:120934. [DOI: 10.1016/j.jorganchem.2019.120934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
21 Rukk NS, Kuz’mina LG, Davydova GA, Buzanov GA, Retivov VM, Belus SK, Kozhukhova EI, Barmashov AE, Khrulev AA, Simonova MA, Krasnoperova VN. Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine. Mendeleev Communications 2019;29:640-2. [DOI: 10.1016/j.mencom.2019.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
22 Soliman AA, Attaby FA, Alajrawy OI, Majeed SR, Sahin C, Varlikli C. Soluble Cytotoxic Ruthenium(II) Complexes with 2-Hydrazinopyridine. Russ J Inorg Chem 2019;64:742-54. [DOI: 10.1134/s0036023619060020] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, Dieci MV, Granziera E, Cemazar M, Alaibac M, Sersa G. Electrochemotherapy of superficial tumors - Current status:: Basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019;46:173-91. [PMID: 31122761 DOI: 10.1053/j.seminoncol.2019.04.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
24 Simunkova M, Lauro P, Jomova K, Hudecova L, Danko M, Alwasel S, Alhazza IM, Rajcaniova S, Kozovska Z, Kucerova L, Moncol J, Svorc L, Valko M. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity. Journal of Inorganic Biochemistry 2019;194:97-113. [DOI: 10.1016/j.jinorgbio.2019.02.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
25 Zhang C, Cai D, Chen S, Liu W, Xiong Y, Le X. Synthesis, DNA interaction and SOD-like activities of copper(II) complexes: investigation of their DNA-interaction mechanism. Transit Met Chem 2019;44:603-13. [DOI: 10.1007/s11243-019-00320-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Tesarova B, Charousova M, Dostalova S, Bienko A, Kopel P, Kruszyński R, Hynek D, Michalek P, Eckschlager T, Stiborova M, Adam V, Heger Z. Folic acid-mediated re-shuttling of ferritin receptor specificity towards a selective delivery of highly cytotoxic nickel(II) coordination compounds. International Journal of Biological Macromolecules 2019;126:1099-111. [DOI: 10.1016/j.ijbiomac.2018.12.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
27 Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019;53:148-58. [PMID: 30956230 DOI: 10.2478/raon-2019-0018] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 28.7] [Reference Citation Analysis]
28 Cavicchioli M, Zaballa A, Paula Q, Prieto M, Oliveira C, Civitareale P, Ciriolo M, Da Costa Ferreira A. Oxidative Assets Toward Biomolecules and Cytotoxicity of New Oxindolimine-Copper(II) and Zinc(II) Complexes. Inorganics 2019;7:12. [DOI: 10.3390/inorganics7020012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Aydın A, Karadağ A, Tekin Ş, Akbaş H. Three new dicyanidoaurate(I)-based complexes exhibiting significant antiproliferative property: synthesis and characterization. Gold Bull 2019;52:35-50. [DOI: 10.1007/s13404-018-00251-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Deo KM, Sakoff J, Gilbert J, Zhang Y, Aldrich Wright JR. Synthesis, characterisation and potent cytotoxicity of unconventional platinum( iv ) complexes with modified lipophilicity. Dalton Trans 2019;48:17217-27. [DOI: 10.1039/c9dt03339d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
31 Crespo M. Cyclometallated platinum(IV) compounds as promising antitumour agents. Journal of Organometallic Chemistry 2019;879:15-26. [DOI: 10.1016/j.jorganchem.2018.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Vellampatti S, Chandrasekaran G, Mitta SB, Dugasani SR, Lakshmanan VK, Park SH. Bacterial Resistance and Prostate Cancer Susceptibility Toward Metal-Ion-doped DNA Complexes. ACS Appl Mater Interfaces 2018;10:44290-300. [PMID: 30550272 DOI: 10.1021/acsami.8b17013] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Guerrero-Palomo G, Rendón-Huerta EP, Montaño LF, Fortoul TI. Vanadium compounds and cellular death mechanisms in the A549 cell line: The relevance of the compound valence. J Appl Toxicol 2019;39:540-52. [PMID: 30407648 DOI: 10.1002/jat.3746] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
34 Zhang C, Liu Y, Zhang X, Chen S, Shen F, Xiong Y, Liu W, Mao Z, Le X. Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids. Materials Science and Engineering: C 2018;91:414-25. [DOI: 10.1016/j.msec.2018.05.065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
35 Shobha Devi C, Thulasiram B, Aerva RR, Nagababu P. Recent Advances in Copper Intercalators as Anticancer Agents. J Fluoresc 2018;28:1195-205. [DOI: 10.1007/s10895-018-2283-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
36 Streciwilk W, Terenzi A, Cheng X, Hager L, Dabiri Y, Prochnow P, Bandow JE, Wölfl S, Keppler BK, Ott I. Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction. Eur J Med Chem 2018;156:148-61. [PMID: 30006161 DOI: 10.1016/j.ejmech.2018.06.056] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
37 Soliman AA, Attaby FA, Alajrawy OI, Majeed SR. Soluble ruthenium(II) with 3,4-diaminobenzoic acid complexes: Preparation, thermal study, theoretical calculations and in vitro cytotoxic activity. J Therm Anal Calorim 2019;135:2457-73. [DOI: 10.1007/s10973-018-7405-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Hormann J, Malina J, Lemke O, Hülsey MJ, Wedepohl S, Potthoff J, Schmidt C, Ott I, Keller BG, Brabec V, Kulak N. Multiply Intercalator-Substituted Cu(II) Cyclen Complexes as DNA Condensers and DNA/RNA Synthesis Inhibitors. Inorg Chem 2018;57:5004-12. [DOI: 10.1021/acs.inorgchem.8b00027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
39 Edeler D, Arlt S, Petković V, Ludwig G, Drača D, Maksimović-ivanić D, Mijatović S, Kaluđerović GN. Delivery of [Ru(η6-p-cymene)Cl2{Ph2P(CH2)3SPh-κP}] using unfunctionalized and mercapto functionalized SBA-15 mesoporous silica: Preparation, characterization and in vitro study. Journal of Inorganic Biochemistry 2018;180:155-62. [DOI: 10.1016/j.jinorgbio.2017.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhang C, Zhang X, Liu W, Chen S, Le X. A copper(II) complex of 6-(pyrazin-2-yl)-1,3,5-triazine-2,4-diamine and L-serinate: synthesis, crystal structure, DNA-binding and molecular docking studies. Transit Met Chem 2018;43:201-9. [DOI: 10.1007/s11243-017-0200-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
41 Deng J, Su G, Chen P, Du Y, Gou Y, Liu Y. Evaluation of DNA binding and DNA cleavage of nickel(II) complexes with tridentate α-N-heterocyclic thiosemicarbazones ligands. Inorganica Chimica Acta 2018;471:194-202. [DOI: 10.1016/j.ica.2017.11.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
42 Qi Y, Liu Y, Gan Q, Xiong Y, Mao Z, Le X. Three new mixed‐ligand copper(II) complexes containing glycyl‐ l ‐valine and N,N‐aromatic heterocyclic compounds: Synthesis, characterization, DNA interaction, cytotoxicity and antimicrobial activity. Appl Organometal Chem 2017;32:e4126. [DOI: 10.1002/aoc.4126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
43 Bailis JM, Weidmann AG, Mariano NF, Barton JK. Rhodium metalloinsertor binding generates a lesion with selective cytotoxicity for mismatch repair-deficient cells. Proc Natl Acad Sci U S A 2017;114:6948-53. [PMID: 28634291 DOI: 10.1073/pnas.1706665114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
44 Sinopoli A, Wood CJ, Gibson EA, Elliott PI. New cyclometalated iridium(III) dye chromophore complexes for p-type dye-sensitised solar cells. Dyes and Pigments 2017;140:269-77. [DOI: 10.1016/j.dyepig.2017.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
45 Karaca Ö, Meier-menches SM, Casini A, Kühn FE. On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging. Chem Commun 2017;53:8249-60. [DOI: 10.1039/c7cc03074f] [Cited by in Crossref: 42] [Cited by in F6Publishing: 6] [Article Influence: 8.4] [Reference Citation Analysis]